Chartwell Investment Partners, LLC Ultragenyx Pharmaceutical Inc. Transaction History

Chartwell Investment Partners, LLC

  • $2.91 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 15, 2023
BUY
$33.72 - $46.33 $15,578 - $21,404
462 Added 6.06%
8,085 $374,000
Q3 2022

Oct 27, 2022
BUY
$39.96 - $66.14 $10,709 - $17,725
268 Added 3.64%
7,623 $316,000
Q2 2022

Aug 01, 2022
BUY
$45.8 - $85.4 $336,859 - $628,117
7,355 New
7,355 $439,000

Others Institutions Holding RARE

# of Institutions
325
Shares Held
85.5M
Call Options Held
520K
Put Options Held
406K
View Full List

About Ultragenyx Pharmaceutical Inc.

RARE Quotes by TradingView
  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $3.01B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Chartwell Investment Partners, LLC Portfolio

Follow Chartwell Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chartwell Investment Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email